Tue.May 30, 2023

article thumbnail

Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit

Fierce Pharma

Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit zbecker Tue, 05/30/2023 - 10:24

292
292
article thumbnail

SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine

Pharmaceutical Technology

SK Bioscience has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for its Covid-19 vaccine, SKYCovion. SKYCovion is intended for the prevention of Covid-19 resulting from SARS-CoV-2 infection in individuals aged 18 years and above. The authorisation allows the distribution of the vaccine in Scotland, Wales and England.

Medicine 119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lexicon finally scores FDA nod for heart failure drug Inpefa

Fierce Pharma

Lexicon finally scores FDA nod for heart failure drug Inpefa kdunleavy Tue, 05/30/2023 - 05:46

FDA 233
article thumbnail

US companies drive 2023 drug launches positioned for blockbuster success by 2028

Pharmaceutical Technology

According to GlobalData’s Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 are projected to attain blockbuster status or near-blockbuster status by 2028 with US company dominance. Lecanemab by Eisai Co Ltd, a monoclonal antibody therapy marketed for Alzheimer’s disease, is predicted to achieve the most significant commercial debut.

Pharma 105
article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

Persistent Sun Pharma ready to complete Taro buyout—16 years after initial offer

Fierce Pharma

Persistent Sun Pharma ready to complete Taro buyout—16 years after initial offer kdunleavy Tue, 05/30/2023 - 09:57

Pharma 208
article thumbnail

How Employers Can Get Started in the Food as Medicine Movement

MedCity News

Employers have a responsibility to support the food as medicine movement and help employees who are food insecure, said Jay Bhatt, managing director of Deloitte Services and managing director of the Center for Health Solutions and Health Equity Institute. He made these comments last week at the MedCity INVEST conference in Chicago.

Medicine 101

More Trending

article thumbnail

Does Improved Medical Billing Increase Revenue?

Referral MD

Photo by Marek Studzinski on Unsplash The medical billing process can be a tedious, lengthy, and complex one. This can leave healthcare practitioners struggling to stay afloat financially. Can a healthcare practice increase revenue by improving its medical billing process? A reliable medical billing service or software can help reduce backlogs and increase revenue.

Medical 97
article thumbnail

After price cuts, Eli Lilly inks $13.5M settlement in long-running insulin lawsuit

Fierce Pharma

After price cuts, Eli Lilly inks $13.

292
292
article thumbnail

Amplo Biotechnology receives NIH-NIAMS grant for gene therapy AMP-201

Pharmaceutical Technology

Amplo Biotechnology has received a fast track phase I/II STTR grant from the NIH-NIAMS [National Institutes of Health’s National Institute of Arthritis and Musculoskeletal and Skin Diseases] for its gene therapy AMP-201. The company will receive substantial funding to advance AAV-ColQ gene therapy. AMP-201 addresses the severe congenital myasthenic syndrome (CMS) caused by collagen Q (ColQ) deficiency.

article thumbnail

A glimpse into public perception of mental health care in the United States

Clarify Health

Addressing the mental health crisis in the United States is a complex undertaking, due to multiple factors contributing to prevalence and severity of several conditions. Recent findings from the Clarify Health Institute highlight these growing problems and speak to a need for action to combat this crisis. According to its most recent research brief, “The Kids Are Not Alright: Mental Health Utilization Among Children and Young Adults, 2016-2022,” hospital admissions for mental illnes

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Burnout Continues To Crush Clinicians, But Voice Tech and AI Could Help

MedCity News

In addition to reducing workload, NLP and ambient voice technology can also improve the quality of care that clinicians provide. By analyzing EHRs and other patient data, NLP algorithms can identify potential health risk factors and recommend preventative measures.

article thumbnail

AION Labs and BioMed X launch sixth challenge for AI-driven drug discovery

Pharmaceutical Technology

Last week, artificial intelligence (AI) innovator AION Labs called for applications for its latest AI-powered startup. In partnership with BioMed X, the Israeli company hopes to attract top talent from across the globe to develop an AI platform capable of discovering new high-affinity small molecules. Launched back in 2021, AION Labs was formed as an alliance between AstraZeneca , Merck , Pfizer and Teva , as well as Amazon and the Israel Biotech Fund.

Pharma 84
article thumbnail

After FDA Miss in Diabetes, Lexicon Lands Long-Awaited Approval in Heart Failure

MedCity News

Lexicon Pharmaceuticals drug Inpefa is now FDA-approved for heart failure. Inpefa is third in its class, but the biotech says its pill can reach a specific subset of patients, enabling it to stand apart from rival medicines from AstraZeneca and partners Eli Lilly and Boehringer Ingelheim.

FDA 90
article thumbnail

Smart Sutures Sense Inflammation, Deliver Drugs, Cells

Medgadget

Researchers at MIT have developed smart sutures with a hydrogel coating that contains sensing and drug delivery components, and could even be used to implant therapeutic cells. The sutures are made using pig tissues that have been decellularized with detergents to reduce the possibility that they could provoke an immune reaction. The surrounding hydrogel layer contains microparticles that can release peptides when enzymes involved in inflammation are present, and other microparticles that allow

article thumbnail

ABM Evolution: How Top Marketers Are Using Account-Based Strategies

In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.

article thumbnail

Federal Agencies Release New Guidelines to Help Providers Fend Off Ransomware

MedCity News

A group of federal agencies recently released an updated set of guidelines to help healthcare organizations protect themselves from ransomware attacks and the data breaches that often follow. The guidance lays out best practices to prevent the six major ways that bad actors gain access to providers’ systems, which include compromised credentials and phishing.

article thumbnail

European Commission approves haematology biosimilar

European Pharmaceutical Review

The European Commission (EC) has granted a marketing authorisation for EPYSQLI , a biosimilar to Soliris (eculizumab) for adults and children patients with paroxysmal nocturnal haemoglobinuria (PNH). “The approval of EPYSQLI , Samsung Bioepis’ first haematology biosimilar, reflects our ongoing endeavours to introduce more treatment options for PNH patients in Europe,” stated Byoungin Jung, Vice President and Regulatory Affairs Team Leader at Samsung Bioepis.

article thumbnail

Pfizer Hemophilia Drug Reduces Bleeding in Key Study; Regulatory Filings Are Planned

MedCity News

Marstacimab, a Pfizer drug for both hemophilia A and B, met the main goal of a Phase 3 study and the company now plans to discuss the data with regulators. The Pfizer drug could beat to the market a Novo Nordisk drug that addresses the same novel target.

article thumbnail

siRNA as a COVID-19 Treatment

Medgadget

Researchers at UMass Chan Medical School have developed a small interfering RNA (siRNA) technology that is stable enough for inhalation into the lungs, where it can potentially treat diseases as diverse as asthma, pulmonary fibrosis, and viral infections such as COVID-19. siRNA is not typically stable enough to survive for long in the lungs, but the researchers chemically modified the constituent nucleotides to stabilize the molecules and help them to evade immune destruction.

Medical 71
article thumbnail

ABM Success Recipe: Mastering the Crawl, Walk, Run Approach

Shifting to an account-based marketing (ABM) strategy can be both exciting and challenging. Well-implemented ABM motions build engagement with high-value accounts and drive impactful campaigns that resonate with your audience. But where do you begin, and how do you progress from crawling to running? Watch now as Demand Gen experts delve into the essentials of each stage of the ABM process.

article thumbnail

Digital Health Funding Steadied in Q1 After a Year of Decline

MedCity News

Global funding for digital health companies finally stabilized in Q1 of this year. The sector raised $3.4 billion — this marks the first time the digital health world didn’t experience a quarter-over-quarter funding decline since Q4 of 2021. By holding steady, digital health startups defied the dwindling fundraising totals seen across the broader venture capital landscape, where funding dropped by 13% quarter-over-quarter.

84
article thumbnail

AstraZeneca’s Ultomiris approved in Japan for prevention of relapses in patients with NMOSD

PharmaTimes

The drug has already been approved for this indication in the EU, with regulatory reviews continuing elsewhere including in the US

article thumbnail

Carrum Health Secures $45M To Expand Cancer Care Offerings for Employers

MedCity News

Carrum Health’s $45 million funding round was led by OMERS Growth Equity and included participation from Revelation Partners, Tiger Global, Wildcat Venture Partners, Cross Creek and SpringRock Ventures. It brings the company’s total financing to about $96 million.

82
article thumbnail

Increase Psychological Safety and Create High-Performing Medical Sales Teams

MedReps

In order for teams to work together more effectively, each person involved needs to have respect for the others in the group. This is true in many different settings, including those who work in medical sales. For a medical sales team to become a high-performing one, they first need to make sure there’s a long-standing tradition of psychological safety involved for everyone in the group.

article thumbnail

How Intent Data Helps Marketers Convert A-List Accounts

One of the biggest challenges for any B2B marketer is understanding your prospects’ next move — who is most likely to buy and when. Without these insights, marketing campaigns can feel more like guesswork, with high investment and little return. We’re here to tell you there’s a better way. By tracking buyers’ digital footprints and online activity, such as website visits, product reviews, and spikes in content consumption, you can engage prospects with a message that really resonates.

article thumbnail

EU regulator recommends revoking approval for Novartis’ sickle cell disease drug

PharmaTimes

The EMA's human medicines committee concluded that the benefits of Adakveo did not outweigh its risks

article thumbnail

Early signals suggest oral SERD’s potential for more breast cancer patients

Pharmaceutical Technology

The Menarini Group today has announced exploratory results from its EMERALD clinical study that suggest its recently approved oral selective estrogen receptor downregulator (SERD) Orserdu (elacestrant) could have potential in a wider group of patients with metastatic breast cancer. In January, the oral SERD Orserdu made waves by becoming the first approved drug to treat patients with estrogen receptor (ER)+, human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast

article thumbnail

Why the rise of intellectual property value means IP leaders need better budget management

Clarivate

As the business value of intellectual property (IP) continues to grow, the need to manage IP as a strategic asset is greater than ever. As of 2018, intangible assets accounted for 84% of market capitalization for S&P 500 companies , compared to just 12% four decades ago. While 95% of senior corporate decision makers believe these intangible assets predict future strength , many organizations still fall short in their strategic IP management.

article thumbnail

Novartis Purchases Cystinosis Gene Therapy from AVROBIO

PharmaTech

The $87.5 million purchase grants Novartis rights to an investigational gene therapy program intended for treatment of cystinosis.

97
article thumbnail

Solving the Biggest Tech Challenges in RevOps

In this eBook, we’ll run through real-world examples that show how RevOps teams can benefit from modern solutions for the access, management, and activation of their GTM data. Whether you need to improve lead response times, boost adoption of core tools, improve lead qualification, or target and automate your GTM motions, you’ll find examples of how revenue teams are solving some of the toughest problems in modern business.

article thumbnail

Lexicon Receives FDA Stamp of Approval for New Heart Failure Treatment

PharmExec

Inpefa to support multiple cardiovascular issues.

FDA 98
article thumbnail

Sales Skills You Will Need As A Medical Sales Rep With Andy Olen

Evolve Your Success

Master the art of sales in the medical field and unlock your true potential as a representative. Gain the essential skills that inspire customers to say yes, paving the way for success and making a lasting impact in healthcare. Welcome to the Medical Sales podcast. Today, host Samuel Adeyinka is joined by special guest, Andy Olen. In this episode, he discusses the essential sales skills required for success as a medical sales representative.

article thumbnail

12 Ways to Generate High-Quality Solar Sales Leads

Spotio

The solar industry continues to grow, as does the competition to acquire new customers. Of course, the only way to acquire new customers is to first generate quality solar leads. It’s not always easy, but it’s far from impossible. We’re about to teach you exactly how to get solar leads for your business in 2023 using 12 proven strategies.

Leads 52
article thumbnail

THINK Surgical Receives FDA 510(k) Clearance for TMINI Miniature Robotic System

Legacy MEDSearch

THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced that its TMINI Miniature Robotic System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The TMINI system includes a wireless robotic handpiece that assists surgeons in performing total knee replacement. Following a CT based three-dimensional surgical plan, the TMINI robotic handpiece automatically compensates for surgeon hand movement to locate bone pins along precisely

FDA 52
article thumbnail

Drive GTM Efficiency with Tech Stack Consolidation

Consolidating your tech stack is an effective cost-saving measure that drives GTM efficiency and adds value to your enterprise. With a cohesive, integrated tech stack, your revenue teams can deliver an excellent customer experience that sets you up to win faster than your competitors.